首页> 美国卫生研究院文献>Molecules >Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives
【2h】

Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives

机译:新型杂环侧耳素衍生物的合成及生物活性评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of pleuromutilin derivatives were synthesized by two synthetic procedures under mild reaction conditions and characterized by Nuclear Magnetic Resonance (NMR), Infrared Spectroscopy (IR), and High Resolution Mass Spectrometer (HRMS). Most of the derivatives with heterocyclic groups at the C-14 side of pleuromutilin exhibited excellent in vitro antibacterial activities against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus epidermidis (MRSE), and vancomycin-resistant Enterococcus (VRE) in vitro antibacterial activity. The synthesized derivatives which contained pyrimidine rings, >3a, >3b, and >3f, displayed modest antibacterial activities. Compound >3a, the most active antibacterial agent, displayed rapid bactericidal activity and affected bacterial growth in the same manner as that of tiamulin fumarate. Moreover, molecular docking studies of >3a and lefamulin provided similar information about the interactions between the compounds and 50S ribosomal subunit. The results of the study show that pyrimidine rings should be considered in the drug design of pleuromutilin derivatives.
机译:在温和的反应条件下,通过两种合成方法合成了一系列截短侧耳素衍生物,并通过核磁共振(NMR),红外光谱(IR)和高分辨率质谱仪(HRMS)进行了表征。截短侧耳素C-14侧具有杂环基团的大多数衍生物对金黄色葡萄球菌,耐甲氧西林的金黄色葡萄球菌(MRSA),耐甲氧西林的表皮葡萄球菌(MRSE)和耐万古霉素的肠球菌(VRE)表现出优异的体外抗菌活性)体外抗菌活性。含有嘧啶环,> 3a ,> 3b 和> 3f 的合成衍生物显示出适度的抗菌活性。活性最强的化合物> 3a 具有与富马酸替米林相同的快速杀菌活性,并影响细菌的生长。此外,> 3a 和Lefamulin的分子对接研究提供了有关化合物与50S核糖体亚基之间相互作用的类似信息。研究结果表明,嘧啶环素衍生物的药物设计应考虑使用嘧啶环。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号